BIO vs USPH · rev $2.58B vs P/E 34, rev $671.3M
BIO (BIO) versus US Physicalrapy Inc (USPH) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
US Physicalrapy Inc (USPH) is a medical care facilities company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported USPH revenue for 2024-12-31 was $671.3M. Net income was $45.6M. Revenue was up 11.0% from 2023-12-31 to 2024-12-31. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
BIO currently screens at market cap $0. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
Not investment advice. Open the BIO and USPH stock pages for the full models.
Not investment advice.